Ampio gets FDA feedback on proposed modifications to special protocol assessment for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced it received guidance from the U.S Food Drug Administration regarding the impact of COVID-19 on its Phase III clinical... Read More
Wednesday December 30, 2020
Welltok is COVID-19 communication engine for vaccine manufacturers, insurers, hospitals
DENVER --With the greatest public health crisis of our time, it is the responsibility of every healthcare organization to boost COVID-19 testing and vaccine awareness and education campaigns. ... Read More
Thursday December 24, 2020
BioIntelliSense BioButton named CES 2021 Best of Innovation Award honoree
DENVER -- BioIntelliSense, Inc. announced it has been named Best of Innovation as a CES 2021 Innovation Awards honoree for the BioButton medical-grade wearable device and data services. The "Best... Read More
Monday December 21, 2020
Ampion demonstrates safety in COVID patients and initiates global trial for intravenous Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it hascompleted its Phase I clinical trial and has initiated the first steps for a global Phase II clinical trial for... Read More
Friday December 18, 2020
Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug,... Read More
Monday December 14, 2020
InDevR expands commercial portfolio for coronavirus vaccine characterizationÂ
BOULDER -- InDevR, Inc. , a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial... Read More
Thursday December 10, 2020
Ampio's Phase I study for inhaled Ampion advances to completing enrollment of COVID-19 patients
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced its AP-014 Phase I inhaled Ampion clinical study in COVID-19 patients is proceeding to full open enrollment following... Read More
Friday December 4, 2020
Clean Republic expands smart clean movement with consumer launch of EPA and ECHA-approved Disinfectant + Sanitizer
BOULDER -- Clean Republic, makers of OMRI-certified, nature-derived cleaning products, announced the U.S. consumer launch of their EPA and ECHA-approved Disinfectant + Sanitizer. The product is... Read More
Thursday December 3, 2020
IN Sponsors
Browse
Entrepreneurial by Nature
